SUBSCRIBE
SUBSCRIBE
News   FDA

AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug

October 20, 2008 | 
1 min read
CAMBRIDGE, Mass. - Biotechnology company AMAG Pharmaceuticals Inc. said Monday the Food and Drug Administration wants more information on a prospective anemia drug before considering it for approval.
FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
March 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of businessman with flag looking victorious on top of teetering blocks
Approvals
Rhythm Bounces Back from Phase 3 Fail with FDA Nod for Rare Obesity Injection
March 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Traffic light in green color, with the dusk sky in the background.
Approvals
Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod
March 19, 2026
 · 
2 min read
 · 
Heather McKenzie
Man walking on a long wavy path with flag at the end, persistence, determination and ultimate business success - 3D Render
FDA
Sarepta Plans FDA Run for Duchenne Exon Skippers Despite Confirmatory Trial Failure
March 19, 2026
 · 
2 min read
 · 
Annalee Armstrong